Primary hyperparathyroidism (PHPT) in children is a rare disorder with sharp contrasts in its presentation and aetiology compared with the disease process in adults. This review outlines the current literature, which is limited to about 200 cases, with reference to the aetiology, clinical features, outcomes of investigations, and surgery in children affected by PHPT. Familial conditions account for almost half of all cases of PHPT in children, suggesting that routine genetic testing would be appropriate. Neonatal severe hyperparathyroidism requires urgent medical attention, and performing total parathyroidectomies offers cure, though conservative management is successful in selected cases. Familial hyperparathyroidism in older children can be caused by conditions such as multiple endocrine neoplasia types 1 and 2a, hyperparathyroidism-jaw tumour syndrome and familial hyperparathyroidism. The role of surgery for this group is discussed. The use of ultrasound and MIBI (99mTc-methoxyisobutylnitrile) scanning appears to accurately localise solitary adenomas in sporadic PHPT, thereby supporting the role of minimally invasive parathyroidectomy in children.

Keywords:
Primary hyperparathyroidism, Familial hyperparathyroidism, Parathyroid surgery, Paediatric parathyroid surgery, Minimally invasive parathyroidectomy
1.
Fraser WD: Hyperparathyroidism. Lancet 2009;374:145-158.
2.
Kollars J, Zarroug AE, van Heerden J, Lteif A, Stavlo P, Suarez L, Moir C, Ishitani M, Rodeberg D: Primary hyperparathyroidism in pediatric patients. Pediatrics 2005;115:974-980.
3.
Mallet E; Working Group on Calcium Metabolism: Primary hyperparathyroidism in neonates and childhood. The French experience (1984-2004). Horm Res 2008;69:180-188.
4.
Durkin ET, Nichol PF, Lund DP, Chen H, Sippel RS: What is the optimal treatment for children with primary hyperparathyroidism? J Pediatr Surg 2010;45:1142-1146.
5.
George J, Acharya SV, Bandgar TR, Menon PS, Shah NS: Primary hyperparathyroidism in children and adolescents. Indian J Pediatr 2010;77:175-178.
6.
Libansky P, Astl J, Adamek S, Nanka O, Pafko P, Spackova J, Foltan R, Sedy J: Surgical treatment of primary hyperparathyroidism in children: report of 10 cases. Int J Pediatr Otorhinolaryngol 2008;72:1177-1182.
7.
Al-Shanafey S, Al Hosaini R, Al Ashwal A, Al Rabeeah A: Surgical management of severe neonatal hyperparathyroidism: one center's experience. J Pediatr Surg 2010;45:714-717.
8.
Lawson ML, Miller SF, Ellis G, Filler RM, Kooh SW: Primary hyperparathyroidism in a paediatric hospital. QJM 1996;89:921-932.
9.
Pashtan I, Grogan RH, Kaplan SP, Devon K, Angelos P, Liu D, Kaplan EL: Primary hyperparathyroidism in adolescents: the same but different. Pediatr Surg Int 2013;29:275-279.
10.
Kruse K: Disorders of calcium and bone metabolism; in Charles Brook (ed): Clinical Pediatric Endocrinology. London, Blackwell Science, 1995, pp 735-778.
11.
Mannix H Jr: Primary hyperparathyroidism in children. Am J Surg 1975;129:528-531.
12.
Rapaport D, Ziv Y, Rubin M, Huminer D, Dintsman M: Primary hyperparathyroidism in children. J Pediatr Surg 1986;21:395-397.
13.
Allo M, Thompson NW, Harness JK, Nishiyama RH: Primary hyperparathyroidism in children, adolescents, and young adults. World J Surg 1982;6:771-776.
14.
Girard RM, Belanger A, Hazel B: Primary hyperparathyroidism in children. Can J Surg 1982;25:11-3, 32.
15.
Harman CR, van Heerden JA, Farley DR, Grant CS, Thompson GB, Curlee K: Sporadic primary hyperparathyroidism in young patients: a separate disease entity? Arch Surg 1999;134:651-655.
16.
Loh KC, Duh QY, Shoback D, Gee L, Siperstein A, Clark OH: Clinical profile of primary hyperparathyroidism in adolescents and young adults. Clin Endocrinol (Oxf) 1998;48:435-443.
17.
Alagaratnam S, Brain C, Spoudeas HA, Dattani MT, Hindmarsh P, Allgrove J, Van't Hoff W, Kurzawinski TR: Surgical treatment of children with hyperparathyroidism: single centre experience. J Pediatr Surg 2014;49:1539-1543.
18.
Lietman SA, Germain-Lee EL, Levine MA: Hypercalcemia in children and adolescents. Curr Opin Pediatr 2010;22:508-515.
19.
Meier DE, Snyder WH, III, Dickson BA, Margraf LR, Guzzetta PC Jr: Parathyroid carcinoma in a child. J Pediatr Surg 1999;34:606-608.
20.
Hamill J, Maoate K, Beasley SW, Corbett R, Evans J: Familial parathyroid carcinoma in a child. J Paediatr Child Health 2002;38:314-317.
21.
DeLellis RA, Mazzaglia P, Mangray S: Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 2008;132:1251-1262.
22.
Kandil E, Alabbas HH, Lum YW, Tufaro AP: Familial isolated primary hyperparathyroidism with double adenoma. South Med J 2010;103:236-238.
23.
Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Brixen K, Mosekilde L: Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf) 2008;69:713-720.
24.
Crowne E, Brain CB, Murday V, Harrison B, Squire R, Buchanan C, Hindmarsh PC, Spoudeas HA: Hyperparathyroidism and pituitary tumours in association with multiple endocrine neoplasia type 1 (MEN1) syndrome; in Spoudeas HA (ed): Paediatric Endocrine Tumours. A multi-disciplinary consensus statement of best practice from a working group convened under the auspices of the BSPED and UKCCSG (rare tumour working groups). Crawley, Novo Nordisk, 2005, pp 107-120.
25.
Murday V, Brain CB, Crowne E, Harrison B, Squire R, Buchanan C, Spoudeas HA: Medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2 (MEN 2) syndromes; in Spoudeas HA (ed): Paediatric endocrine tumours. A multi-disciplinary consensus statement of best practice from a working group convened under the auspices of the BSPED and UKCCSG (rare tumour working groups). Crawley, Novo Nordisk, 2005, pp 93-106.
26.
Patel CN, Scarsbrook AF: Multimodality imaging in hyperparathyroidism. Postgrad Med J 2009;85:597-605.
27.
Ruda JM, Hollenbeak CS, Stack BC Jr: A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005;132:359-372.
28.
Lumachi F, Zucchetta P, Marzola MC, Boccagni P, Angelini F, Bui F, D'Amico DF, Favia G: Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol 2000;143:755-760.
29.
Patel CN, Salahudeen HM, Lansdown M, Scarsbrook AF: Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clin Radiol 2010;65:278-287.
30.
Waller S, Kurzawinski T, Spitz L, Thakker R, Cranston T, Pearce S, Cheetham T, van't Hoff WG: Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr 2004;163:589-594.
31.
Augustine MM, Bravo PE, Zeiger MA: Surgical treatment of primary hyperparathyroidism. Endocr Pract 2011;17(suppl 1):75-82.
32.
Stalberg P, Carling T: Familial parathyroid tumors: diagnosis and management. World J Surg 2009;33:2234-2243.
33.
Scholten A, Schreinemakers JM, Pieterman CR, Valk GD, Vriens MR, Borel R: Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Endocr Pract 2011;17:7-15.
34.
Landry CS, Waguespack SG, Perrier ND: Surgical management of nonmultiple endocrine neoplasia endocrinopathies: state-of-the-art review. Surg Clin North Am 2009;89:1069-1089.
35.
Moffett JM, Suliburk J: Parathyroid autotransplantation. Endocr Pract 2011;17(suppl 1):83-89.
36.
Tan CC, Cheah WK, Tan CT, Rauff A: Intramuscular injection of parathyroid autografts is a viable option after total parathyroidectomy. World J Surg 2010;34:1332-1336.
37.
Feldman AL, Sharaf RN, Skarulis MC, Bartlett DL, Libutti SK, Weinstein LS, Marx SJ, Norton JA, Fraker DL, Alexander HR: Results of heterotopic parathyroid autotransplantation: a 13-year experience. Surgery 1999;126:1042-1048.
38.
Lobe TE, Wright SK: The transaxillary, totally endoscopic approach for head and neck endocrine surgery in children. J Laparoendosc Adv Surg Tech A 2011;21:97-100.
39.
Gagner M: Endoscopic subtotal parathyroidectomy in patients with primary hyperparathyroidism. Br J Surg 1996;83:875.
40.
Henry JF, Sebag F, Tamagnini P, Forman C, Silaghi H: Endoscopic parathyroid surgery: results of 365 consecutive procedures. World J Surg 2004;28:1219-1223.
41.
Dutta S, Slater B, Butler M, Albanese CT: ‘Stealth surgery': transaxillary subcutaneous endoscopic excision of benign neck lesions. J Pediatr Surg 2008;43:2070-2074.
42.
Miccoli P, Bendinelli C, Conte M, Pinchera A, Marcocci C: Endoscopic parathyroidectomy by a gasless approach. J Laparoendosc Adv Surg Tech A 1998;8:189-194.
43.
Sackett WR, Barraclough B, Reeve TS, Delbridge LW: Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 2002;137:1055-1059.
44.
Udelsman R: Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002;235:665-670.
45.
Nilsen FS, Haug E, Heidemann M, Karlsen SJ: Does rapid intraoperative parathyroid hormone analysis predict cure in patients undergoing surgery for primary hyperparathyroidism? A prospective study. Scand J Surg 2006;95:28-32.
46.
Lobe TE, Wright SK: The transaxillary, totally endoscopic approach for head and neck endocrine surgery in children. J Laparoendosc Adv Surg Tech A 2011;21:97-100.
47.
Miccoli P, Berti P, Materazzi G, Massi M, Picone A, Minuto MN: Results of video-assisted parathyroidectomy: single institution's six-year experience. World J Surg 2004;28:1216-1218.
48.
Westra WH, Pritchett DD, Udelsman R: Intraoperative confirmation of parathyroid tissue during parathyroid exploration: a retrospective evaluation of the frozen section. Am J Surg Pathol 1998;22:538-544.
49.
Saxe AW, Baier R, Tesluk H, Toreson W: The role of the pathologist in the surgical treatment of hyperparathyroidism. Surg Gynecol Obstet 1985;161:101-105.
50.
Harrison BJ, Triponez F: Intraoperative adjuncts in surgery for primary hyperparathyroidism. Langenbecks Arch Surg 2009;394:799-809.
51.
Pollack G, Pollack A, Delfiner J, Fernandez J: Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use. Laryngoscope 2009;119:1941-1946.
52.
Bergenfelz AO, Hellman P, Harrison B, Sitges-Serra A, Dralle H: Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg 2009;394:761-764.
53.
Suzuki T, Numata T, Shibuya M: Intraoperative photodynamic detection of normal parathyroid glands using 5-aminolevulinic acid. Laryngoscope 2011;121:1462-1466.
54.
Prosst RL, Weiss J, Hupp L, Willeke F, Post S: Fluorescence-guided minimally invasive parathyroidectomy: clinical experience with a novel intraoperative detection technique for parathyroid glands. World J Surg 2010;34:2217-2222.
55.
Murphy C, Norman J: The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery 1999;126:1023-1028.
56.
Rubello D, Mariani G, Pelizzo MR: Minimally invasive radio-guided parathyroidectomy on a group of 452 primary hyperparathyroid patients: refinement of preoperative imaging and intraoperative procedure. Nuklearmedizin 2007;46:85-92.
57.
Chen H, Sippel RS, Schaefer S: The effectiveness of radioguided parathyroidectomy in patients with negative technetium Tc-99m-sestamibi scans. Arch Surg 2009;144:643-648.
58.
Burke JF, Jacobson K, Gosain A, Sippel RS, Chen H: Radioguided parathyroidectomy effective in pediatric patients. J Surg Res 2013;184:312-317.
59.
Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, Wang CA: Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery 1988;104:1121-1127.
60.
Carter AB, Howanitz PJ: Intraoperative testing for parathyroid hormone: a comprehensive review of the use of the assay and the relevant literature. Arch Pathol Lab Med 2003;127:1424-1442.
61.
Hwang RS, Morris LF, Ro K, Park S, Ituarte PH, Hong JC, Yeh MW: A selective, Bayesian approach to intraoperative PTH monitoring. Ann Surg 2010;251:1122-1126.
62.
Conrad DN, Olson JE, Hartwig HM, Mack E, Chen H: A prospective evaluation of novel methods to intraoperatively distinguish parathyroid tissue utilizing a parathyroid hormone assay. J Surg Res 2006;133:38-41.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.